Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Autolus Therapeutics plc - American Depositary Shares (NQ:AUTL)

1.950 +0.130 (+7.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,204,030
Open 1.820
Bid (Size) 1.920 (5,000)
Ask (Size) 2.000 (1,300)
Prev. Close 1.820
Today's Range 1.800 - 2.020
52wk Range 1.175 - 2.520
Shares Outstanding 52,346,231
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Autolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026
From Autolus Therapeutics plc
Via GlobeNewswire
Top stock movements in today's session. ↗
Via Chartmill

Performance

YTD
+4.3%
+4.3%
1 Month
+19.6%
+19.6%
3 Month
+24.2%
+24.2%
6 Month
+41.3%
+41.3%
1 Year
-18.1%
-18.1%

More News

Read More
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors
From Autolus Therapeutics plc
Via GlobeNewswire
Autolus Therapeutics (NASDAQ:AUTL) Posts Inline Q1 Results with First Positive Gross Margin, but Full-Year Guidance Slightly Below Consensus ↗
Via Chartmill
News headline image
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus Therapeutics to Participate in Upcoming Investor Conference
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus Therapeutics Receives Prix Galien UK Award
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus Therapeutics to Participate in Upcoming Investor Conferences
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus (AUTL) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Autolus Therapeutics Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus Therapeutics Announces Initiative to Support Operational Efficiency and Cost Reduction
From Autolus Therapeutics plc
Via GlobeNewswire
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Leads Shift Toward Pipeline-Driven Valuation in Biotech Sector
Via Investor Brand Network
Topics Intellectual Property
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
Via Investor Brand Network
News headline image
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus Therapeutics to Participate in Upcoming Investor Conferences
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
From BioMedWire
Via GlobeNewswire
News headline image
Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
Autolus Therapeutics to Participate in Upcoming Investor Conferences
From Autolus Therapeutics plc
Via GlobeNewswire
News headline image
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
From Equity Insider
Via GlobeNewswire
News headline image
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Autolus Therapeutics plc
Via GlobeNewswire

Frequently Asked Questions

Is Autolus Therapeutics plc - American Depositary Shares publicly traded?
Yes, Autolus Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Autolus Therapeutics plc - American Depositary Shares trade on?
Autolus Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Autolus Therapeutics plc - American Depositary Shares?
The ticker symbol for Autolus Therapeutics plc - American Depositary Shares is AUTL on the Nasdaq Stock Market
What is the current price of Autolus Therapeutics plc - American Depositary Shares?
The current price of Autolus Therapeutics plc - American Depositary Shares is 1.950
When was Autolus Therapeutics plc - American Depositary Shares last traded?
The last trade of Autolus Therapeutics plc - American Depositary Shares was at 08/04/26 04:00 PM ET
What is the market capitalization of Autolus Therapeutics plc - American Depositary Shares?
The market capitalization of Autolus Therapeutics plc - American Depositary Shares is 102.08M
How many shares of Autolus Therapeutics plc - American Depositary Shares are outstanding?
Autolus Therapeutics plc - American Depositary Shares has 102M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.